Concepts (282)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 1 | 67 | 2024 | 3416 | 4.290 |
Why?
|
| Diabetes Complications | 13 | 2023 | 1315 | 1.310 |
Why?
|
| Hypoglycemia | 18 | 2015 | 883 | 1.090 |
Why?
|
| Erectile Dysfunction | 5 | 2020 | 444 | 0.740 |
Why?
|
| Cognition | 11 | 2024 | 6987 | 0.630 |
Why?
|
| Blood Glucose | 24 | 2022 | 6390 | 0.580 |
Why?
|
| Diabetes Mellitus | 13 | 2015 | 5841 | 0.550 |
Why?
|
| Urinary Incontinence | 5 | 2022 | 490 | 0.530 |
Why?
|
| Self Care | 12 | 2023 | 795 | 0.510 |
Why?
|
| Hyperglycemia | 9 | 2022 | 1375 | 0.490 |
Why?
|
| Patient Education as Topic | 6 | 2009 | 2316 | 0.490 |
Why?
|
| Quality of Life | 12 | 2023 | 13362 | 0.420 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2023 | 2254 | 0.420 |
Why?
|
| Basal Ganglia | 1 | 2015 | 554 | 0.400 |
Why?
|
| Nerve Net | 2 | 2015 | 2290 | 0.400 |
Why?
|
| Prefrontal Cortex | 2 | 2015 | 2219 | 0.390 |
Why?
|
| Diabetic Neuropathies | 3 | 2022 | 406 | 0.340 |
Why?
|
| Glutamic Acid | 2 | 2020 | 1173 | 0.340 |
Why?
|
| Cerebral Cortex | 2 | 2015 | 5777 | 0.300 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2010 | 328 | 0.300 |
Why?
|
| Patient Compliance | 9 | 2001 | 2687 | 0.300 |
Why?
|
| Insulin | 13 | 2022 | 6588 | 0.300 |
Why?
|
| Diabetes Mellitus, Type 2 | 16 | 2019 | 12145 | 0.280 |
Why?
|
| Executive Function | 1 | 2015 | 1388 | 0.270 |
Why?
|
| Glutamine | 1 | 2009 | 574 | 0.270 |
Why?
|
| Social Adjustment | 7 | 2001 | 632 | 0.250 |
Why?
|
| Apolipoproteins E | 1 | 2010 | 1443 | 0.230 |
Why?
|
| Interpersonal Relations | 5 | 2001 | 1437 | 0.220 |
Why?
|
| Sexual Dysfunction, Physiological | 2 | 2018 | 360 | 0.220 |
Why?
|
| Adult | 57 | 2024 | 221083 | 0.220 |
Why?
|
| Brain | 10 | 2023 | 27097 | 0.220 |
Why?
|
| Attitude to Health | 6 | 2001 | 2024 | 0.220 |
Why?
|
| Cognition Disorders | 5 | 2014 | 3974 | 0.210 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2009 | 1140 | 0.210 |
Why?
|
| Depression | 6 | 2016 | 8130 | 0.200 |
Why?
|
| Male | 68 | 2024 | 360675 | 0.200 |
Why?
|
| Middle Aged | 43 | 2024 | 220835 | 0.200 |
Why?
|
| Neuropsychological Tests | 7 | 2023 | 7043 | 0.200 |
Why?
|
| Humans | 93 | 2024 | 761098 | 0.180 |
Why?
|
| Female | 69 | 2024 | 392458 | 0.180 |
Why?
|
| Young Adult | 15 | 2022 | 59199 | 0.180 |
Why?
|
| Hypoglycemic Agents | 9 | 2019 | 3086 | 0.180 |
Why?
|
| Diabetic Retinopathy | 6 | 2015 | 1274 | 0.170 |
Why?
|
| Patient Participation | 1 | 2009 | 1444 | 0.170 |
Why?
|
| Canada | 2 | 2022 | 2125 | 0.170 |
Why?
|
| Insulin Infusion Systems | 3 | 2018 | 217 | 0.160 |
Why?
|
| Hyperinsulinism | 1 | 2022 | 400 | 0.160 |
Why?
|
| Behavior | 1 | 2002 | 540 | 0.160 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2020 | 165 | 0.160 |
Why?
|
| Physician-Patient Relations | 3 | 2015 | 3238 | 0.160 |
Why?
|
| Health Status | 5 | 2015 | 4077 | 0.150 |
Why?
|
| Adolescent | 27 | 2021 | 88271 | 0.150 |
Why?
|
| Psychotherapy, Group | 1 | 2001 | 413 | 0.150 |
Why?
|
| Perception | 4 | 2015 | 1198 | 0.150 |
Why?
|
| Follow-Up Studies | 16 | 2022 | 39121 | 0.150 |
Why?
|
| Gyrus Cinguli | 2 | 2022 | 1114 | 0.140 |
Why?
|
| Sick Role | 3 | 1997 | 229 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 13 | 2024 | 36418 | 0.140 |
Why?
|
| Family | 8 | 1997 | 3193 | 0.140 |
Why?
|
| Epinephrine | 2 | 1999 | 792 | 0.130 |
Why?
|
| Diabetic Nephropathies | 2 | 2015 | 972 | 0.130 |
Why?
|
| Urologic Diseases | 1 | 2018 | 247 | 0.130 |
Why?
|
| Atherosclerosis | 2 | 2011 | 3405 | 0.130 |
Why?
|
| Risk Factors | 15 | 2022 | 74219 | 0.130 |
Why?
|
| Awareness | 1 | 1999 | 649 | 0.120 |
Why?
|
| Connecticut | 1 | 2015 | 364 | 0.120 |
Why?
|
| Adaptation, Psychological | 9 | 2018 | 2632 | 0.120 |
Why?
|
| Automobile Driving | 1 | 1999 | 441 | 0.110 |
Why?
|
| Aged | 16 | 2024 | 169266 | 0.110 |
Why?
|
| Anisotropy | 1 | 2017 | 1284 | 0.110 |
Why?
|
| Renal Dialysis | 2 | 2023 | 1796 | 0.110 |
Why?
|
| Psychotherapy | 3 | 2010 | 1646 | 0.110 |
Why?
|
| Brain Injuries | 1 | 2024 | 2054 | 0.100 |
Why?
|
| Cerebrum | 1 | 2013 | 132 | 0.100 |
Why?
|
| Social Support | 3 | 2001 | 2175 | 0.100 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2015 | 268 | 0.100 |
Why?
|
| Propensity Score | 1 | 2020 | 1913 | 0.100 |
Why?
|
| Lateral Ventricles | 1 | 2013 | 145 | 0.100 |
Why?
|
| Social Environment | 2 | 1994 | 1021 | 0.100 |
Why?
|
| Blood Glucose Self-Monitoring | 4 | 2018 | 468 | 0.090 |
Why?
|
| Acute Disease | 3 | 2020 | 7240 | 0.090 |
Why?
|
| Case-Control Studies | 5 | 2020 | 22157 | 0.090 |
Why?
|
| Research Personnel | 1 | 2015 | 588 | 0.090 |
Why?
|
| Time Factors | 7 | 2021 | 39953 | 0.080 |
Why?
|
| Urinary Tract Infections | 1 | 2016 | 802 | 0.080 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2015 | 709 | 0.080 |
Why?
|
| Cardiovascular System | 1 | 2016 | 836 | 0.080 |
Why?
|
| International Normalized Ratio | 1 | 2010 | 382 | 0.080 |
Why?
|
| History, 21st Century | 1 | 2015 | 1566 | 0.080 |
Why?
|
| Internet | 1 | 2001 | 3094 | 0.080 |
Why?
|
| Health Care Costs | 2 | 2018 | 3238 | 0.080 |
Why?
|
| Memory | 1 | 2017 | 2190 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2015 | 2764 | 0.070 |
Why?
|
| Longitudinal Studies | 7 | 2018 | 14607 | 0.060 |
Why?
|
| Kidney Failure, Chronic | 1 | 2018 | 2478 | 0.060 |
Why?
|
| Neural Pathways | 2 | 2013 | 3057 | 0.060 |
Why?
|
| Leadership | 1 | 2015 | 1386 | 0.060 |
Why?
|
| Memory, Short-Term | 1 | 2011 | 982 | 0.060 |
Why?
|
| Prostate-Specific Antigen | 1 | 2014 | 2465 | 0.060 |
Why?
|
| Drug Monitoring | 1 | 2010 | 961 | 0.060 |
Why?
|
| Demography | 4 | 1997 | 1643 | 0.060 |
Why?
|
| Mental Disorders | 5 | 1997 | 6818 | 0.060 |
Why?
|
| Socioeconomic Factors | 2 | 1997 | 7804 | 0.060 |
Why?
|
| Pilot Projects | 3 | 2023 | 8639 | 0.050 |
Why?
|
| Body Mass Index | 3 | 2016 | 12951 | 0.050 |
Why?
|
| Blood Pressure | 3 | 2016 | 8478 | 0.050 |
Why?
|
| Diabetic Ketoacidosis | 2 | 1997 | 253 | 0.050 |
Why?
|
| Brain Mapping | 2 | 2015 | 6635 | 0.050 |
Why?
|
| Emotions | 4 | 2020 | 2740 | 0.050 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2024 | 550 | 0.050 |
Why?
|
| Hypothalamus | 1 | 2008 | 999 | 0.050 |
Why?
|
| Depressive Disorder | 1 | 2015 | 3727 | 0.050 |
Why?
|
| Neurofilament Proteins | 1 | 2024 | 334 | 0.050 |
Why?
|
| Nursing Evaluation Research | 1 | 2001 | 25 | 0.050 |
Why?
|
| Cross-Sectional Studies | 5 | 2023 | 26068 | 0.050 |
Why?
|
| Warfarin | 1 | 2010 | 1482 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3094 | 0.050 |
Why?
|
| Cooperative Behavior | 1 | 2009 | 1505 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3216 | 0.050 |
Why?
|
| Nurse Clinicians | 1 | 2001 | 30 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 8601 | 0.050 |
Why?
|
| Psychology, Clinical | 1 | 2001 | 42 | 0.050 |
Why?
|
| Diabetic Angiopathies | 1 | 2006 | 805 | 0.050 |
Why?
|
| Social Class | 3 | 1997 | 1993 | 0.050 |
Why?
|
| Inositol | 1 | 2022 | 215 | 0.050 |
Why?
|
| Coronary Stenosis | 1 | 2006 | 802 | 0.040 |
Why?
|
| Atmospheric Pressure | 1 | 2020 | 46 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2023 | 793 | 0.040 |
Why?
|
| Internal-External Control | 2 | 1994 | 358 | 0.040 |
Why?
|
| Fear | 3 | 2001 | 1478 | 0.040 |
Why?
|
| Affect | 2 | 1999 | 1486 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2010 | 4243 | 0.040 |
Why?
|
| Cohort Studies | 5 | 2024 | 41486 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2018 | 5249 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2009 | 3770 | 0.040 |
Why?
|
| Age Factors | 4 | 2008 | 18385 | 0.040 |
Why?
|
| Raynaud Disease | 1 | 1979 | 79 | 0.040 |
Why?
|
| Smoking | 2 | 2010 | 9055 | 0.040 |
Why?
|
| Disease Management | 1 | 2009 | 2508 | 0.040 |
Why?
|
| Child | 11 | 2023 | 80134 | 0.040 |
Why?
|
| Atrophy | 1 | 2023 | 1633 | 0.040 |
Why?
|
| Calcinosis | 1 | 2006 | 1477 | 0.040 |
Why?
|
| Depressive Disorder, Major | 2 | 2010 | 4766 | 0.040 |
Why?
|
| Self Concept | 4 | 1995 | 1046 | 0.040 |
Why?
|
| Regression Analysis | 3 | 1997 | 6343 | 0.040 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1999 | 618 | 0.040 |
Why?
|
| Education | 2 | 1997 | 535 | 0.040 |
Why?
|
| Prevalence | 4 | 2018 | 15717 | 0.040 |
Why?
|
| Physicians | 1 | 2015 | 4583 | 0.030 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2018 | 291 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2016 | 4013 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2018 | 10213 | 0.030 |
Why?
|
| Dementia | 1 | 2011 | 2682 | 0.030 |
Why?
|
| Valsalva Maneuver | 1 | 2016 | 99 | 0.030 |
Why?
|
| Crime | 1 | 1997 | 204 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2009 | 9317 | 0.030 |
Why?
|
| Aging | 2 | 2023 | 8701 | 0.030 |
Why?
|
| Psychophysiologic Disorders | 1 | 1997 | 222 | 0.030 |
Why?
|
| Genotype | 1 | 2010 | 12983 | 0.030 |
Why?
|
| Social Behavior | 2 | 1995 | 1135 | 0.030 |
Why?
|
| Safety | 1 | 2020 | 1151 | 0.030 |
Why?
|
| Anxiety | 3 | 1996 | 4572 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2010 | 4795 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2010 | 6565 | 0.030 |
Why?
|
| Human Growth Hormone | 1 | 1999 | 642 | 0.030 |
Why?
|
| Models, Economic | 1 | 2018 | 714 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 2020 | 1169 | 0.030 |
Why?
|
| tau Proteins | 1 | 2024 | 2094 | 0.030 |
Why?
|
| Hydrocortisone | 2 | 1999 | 1818 | 0.030 |
Why?
|
| Behavior Therapy | 1 | 1979 | 875 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2009 | 4786 | 0.030 |
Why?
|
| Family Relations | 1 | 2015 | 315 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2001 | 2487 | 0.030 |
Why?
|
| Marijuana Abuse | 1 | 1997 | 410 | 0.030 |
Why?
|
| Personality Assessment | 1 | 1994 | 649 | 0.030 |
Why?
|
| Analysis of Variance | 3 | 1999 | 6224 | 0.030 |
Why?
|
| Logistic Models | 2 | 2017 | 13254 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2017 | 970 | 0.020 |
Why?
|
| Cocaine | 1 | 1997 | 958 | 0.020 |
Why?
|
| Body Size | 1 | 2014 | 463 | 0.020 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2018 | 1723 | 0.020 |
Why?
|
| Treatment Refusal | 1 | 1994 | 429 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 1998 | 2696 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2016 | 1702 | 0.020 |
Why?
|
| Hormones | 1 | 1995 | 869 | 0.020 |
Why?
|
| Employment | 1 | 1997 | 1114 | 0.020 |
Why?
|
| Weight Gain | 1 | 2001 | 2349 | 0.020 |
Why?
|
| Hypertension | 1 | 2010 | 8537 | 0.020 |
Why?
|
| Cholesterol | 1 | 1999 | 2902 | 0.020 |
Why?
|
| Glucose | 1 | 2022 | 4341 | 0.020 |
Why?
|
| Age of Onset | 1 | 1997 | 3307 | 0.020 |
Why?
|
| Focus Groups | 1 | 2015 | 1409 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 15513 | 0.020 |
Why?
|
| Nutrition Surveys | 1 | 2016 | 1722 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2018 | 1937 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 2630 | 0.020 |
Why?
|
| Health Surveys | 1 | 2018 | 4036 | 0.020 |
Why?
|
| Sex Factors | 2 | 1999 | 10552 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2001 | 3603 | 0.020 |
Why?
|
| Problem Solving | 1 | 1990 | 443 | 0.020 |
Why?
|
| Diabetic Coma | 1 | 2007 | 8 | 0.020 |
Why?
|
| Inpatients | 1 | 2019 | 2545 | 0.020 |
Why?
|
| Psychological Tests | 2 | 2007 | 639 | 0.020 |
Why?
|
| Mental Health | 1 | 2001 | 3251 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2020 | 10083 | 0.020 |
Why?
|
| Comorbidity | 2 | 2018 | 10514 | 0.020 |
Why?
|
| Thalamus | 1 | 2012 | 1047 | 0.020 |
Why?
|
| Motivation | 1 | 2015 | 2003 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 2012 | 1417 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 5494 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2015 | 3016 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2018 | 6225 | 0.010 |
Why?
|
| Temporal Lobe | 1 | 2012 | 1695 | 0.010 |
Why?
|
| Exercise | 2 | 2018 | 5872 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2020 | 64670 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 1997 | 4028 | 0.010 |
Why?
|
| Boston | 1 | 1997 | 9324 | 0.010 |
Why?
|
| United States | 2 | 2023 | 72337 | 0.010 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2013 | 2401 | 0.010 |
Why?
|
| Ego | 1 | 1983 | 98 | 0.010 |
Why?
|
| Heart Valve Prosthesis | 1 | 2010 | 1463 | 0.010 |
Why?
|
| Psychotic Disorders | 1 | 1997 | 3219 | 0.010 |
Why?
|
| Penis | 1 | 1982 | 212 | 0.010 |
Why?
|
| Homeostasis | 1 | 2012 | 3318 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2007 | 2256 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 1997 | 4414 | 0.010 |
Why?
|
| Reference Values | 1 | 2007 | 4922 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 4849 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 6482 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8663 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 1995 | 4488 | 0.010 |
Why?
|
| Hippocampus | 1 | 2012 | 3757 | 0.010 |
Why?
|
| Mortality | 1 | 2010 | 2896 | 0.010 |
Why?
|
| Skin Temperature | 1 | 1979 | 96 | 0.010 |
Why?
|
| Pain | 1 | 1994 | 5070 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2010 | 3422 | 0.010 |
Why?
|
| Biofeedback, Psychology | 1 | 1979 | 116 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2012 | 3951 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2010 | 54419 | 0.010 |
Why?
|
| Relaxation Therapy | 1 | 1979 | 181 | 0.010 |
Why?
|
| Antidepressive Agents | 1 | 2010 | 2893 | 0.010 |
Why?
|
| Incidence | 1 | 2016 | 21357 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 29672 | 0.010 |
Why?
|
| Discriminant Analysis | 1 | 1997 | 223 | 0.010 |
Why?
|
| Lipids | 1 | 2007 | 3330 | 0.010 |
Why?
|
| Thrombosis | 1 | 2010 | 2944 | 0.010 |
Why?
|
| Fingers | 1 | 1979 | 506 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2013 | 9001 | 0.010 |
Why?
|
| Models, Biological | 1 | 2012 | 9455 | 0.010 |
Why?
|
| Prostheses and Implants | 1 | 1982 | 1276 | 0.010 |
Why?
|
| Pancreatic Hormones | 1 | 1995 | 12 | 0.010 |
Why?
|
| Glucose Clamp Technique | 1 | 1995 | 262 | 0.010 |
Why?
|
| Reproducibility of Results | 3 | 1997 | 20120 | 0.010 |
Why?
|
| Seizures | 1 | 2007 | 2965 | 0.010 |
Why?
|
| Glucagon | 1 | 1995 | 531 | 0.010 |
Why?
|
| Anger | 1 | 1995 | 405 | 0.010 |
Why?
|
| Growth Hormone | 1 | 1995 | 569 | 0.010 |
Why?
|
| Fathers | 1 | 1995 | 375 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2008 | 8000 | 0.010 |
Why?
|
| Norepinephrine | 1 | 1995 | 898 | 0.010 |
Why?
|
| Atrial Fibrillation | 1 | 2010 | 5115 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 1997 | 2081 | 0.010 |
Why?
|
| Intelligence | 1 | 1995 | 922 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2010 | 11475 | 0.010 |
Why?
|
| Personality Inventory | 1 | 1992 | 1017 | 0.000 |
Why?
|
| Stroke | 1 | 2010 | 9720 | 0.000 |
Why?
|
| Cluster Analysis | 1 | 1995 | 2706 | 0.000 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 1997 | 6011 | 0.000 |
Why?
|
| Psychomotor Performance | 1 | 1995 | 1881 | 0.000 |
Why?
|
| Sex Characteristics | 1 | 1995 | 2638 | 0.000 |
Why?
|
| Patient Satisfaction | 1 | 1997 | 3450 | 0.000 |
Why?
|
| Mothers | 1 | 1995 | 2193 | 0.000 |
Why?
|
| Visual Acuity | 1 | 1993 | 2677 | 0.000 |
Why?
|
| Adjustment Disorders | 1 | 1983 | 67 | 0.000 |
Why?
|
| Recurrence | 1 | 1995 | 8456 | 0.000 |
Why?
|
| Coitus | 1 | 1982 | 133 | 0.000 |
Why?
|
| Marriage | 1 | 1982 | 349 | 0.000 |
Why?
|
| Self-Assessment | 1 | 1983 | 399 | 0.000 |
Why?
|
| Vision Disorders | 1 | 1987 | 1088 | 0.000 |
Why?
|
| Personality Disorders | 1 | 1983 | 719 | 0.000 |
Why?
|
| Activities of Daily Living | 1 | 1987 | 2420 | 0.000 |
Why?
|
| Biocompatible Materials | 1 | 1982 | 1684 | 0.000 |
Why?
|
Concepts
(282)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(21)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_